Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities

NCT06662539 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

493

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: Petrelintide
DRUG: Placebo

Sponsor

Zealand Pharma

Collaborators

[object Object]